Gypenoside XLIX ameliorates diabetic retinopathy by downregulating prostaglandin-endoperoxide synthase 2 in retinal pigment epithelium cells to inhibit ferroptosis and preserve tight junction integrity

IntroductionDiabetic retinopathy (DR) represents a prevalent and severe eye complication in diabetic patients. With DR progresses, destruction of tight junctions (TJs) in RPE cells leads to irreversible visual impairment. Gypenoside XLIX (Gyp XLIX) is a dammarane-type glycoside, which can suppress i...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Jiayi Gu, Manhui Zhu, Lele Li, Xin Cao, Xiaoli Yu, Xiaobo Huang, Lili Huang, Qi Cai, Yan Zhu, Wendie Li, Yong Wang
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Frontiers Media S.A. 2026-03-01
Cyfres:	Frontiers in Pharmacology
Pynciau:	diabetic retinopathy ferroptosis gypenoside XLIX networkpharmacology prostaglandin-endoperoxide synthase 2 retinal pigment epithelium
Mynediad Ar-lein:	https://www.frontiersin.org/articles/10.3389/fphar.2026.1777313/full
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!